Introducing a forced-choice recognition task to the California Verbal Learning Test – Children's Version. Issue 3 (3rd April 2017)

• Record Type: Journal Article
• Authors: Lichtenstein, Jonathan D.; Erdodi, Laszlo A.; Linnea, Kate S.
• Is Part Of: Child neuropsychology. Volume 23:Issue 3(2017)
• Page Start: 284
• Page End: 299
• Publication Date: 2017-04-03
• Subjects: CVLT-C -- performance validity testing -- embedded validity indicators -- pediatric PVTs -- effort testing; Pediatric neuropsychology -- Periodicals; Adolescent psychology -- Periodicals; Child development deviations -- Periodicals; Child psychology -- Periodicals; 618.92805
• DOI: 10.1080/09297049.2015.1135422
• Languages: English
• ISSNs: 0929-7049

Abstract

ABSTRACT: The importance of performance validity tests (PVTs) is increasingly recognized in pediatric neuropsychology. To date, research has focused on investigating whether PVTs designed for adults function similarly in children. The downward extension of adult cutoffs is counter-intuitive considering the robust effect of age-related changes in basic cognitive skills in children and adolescents. The purpose of this study was to examine the signal detection properties of a forced-choice recognition trial (FCR-C) for the California Verbal Learning Test – Children's Version. A total of 72 children aged 6–15 years ( M = 11.1 , SD = 2.6) completed the FCR-C as part of a larger neuropsychological assessment battery. Cross-validation analyses revealed that the FCR-C had good signal detection performance against reference PVTs. The first level of failure (≤14/15) produced the best combination of overall sensitivity (.31) and specificity (.87). A more conservative FCR-C cutoff (≤13) resulted in a predictable trade-off between sensitivity (.15) and specificity (.94), but also a net loss in discriminant power. Lowering the cutoff to ≤12 resulted in a slight improvement in specificity (.97) but further deterioration in sensitivity (.14). These preliminary findings suggest that the FCR-C has the potential to become the newest addition to a growing arsenal of pediatric PVTs.